Shearman & Sterling advised the underwriters in the offering.Caribou Biosciences, Inc. executed its initial public offering of 19 million shares of common stock at a public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
